leisure time -WSS

leisure time

author：fashion 2025-10-02 19:38:58 - browse：19

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Moderna says combo Covid

explore

WSS

Readers discuss the intersection of pregnancy and addiction

At flashy new research hub, AstraZeneca lays out ambitious growth goals

ALS patient reclaims some autonomy thanks to wearable 'robot'

ASCO eve: Let’s set the table for this year's meeting

Listen: More tumult at BIO & coercive care for sickle cell patients

Cigna wins case to block Amy Bricker's move to CVS

explore

leisure time

entertainment

Psychedelics group wrestles with new pharma identity

Questions and answers about ramping up H5N1 bird flu vaccine

Trump demands the U.S. pay no more for drugs than other countries … again

Teladoc has a new CEO, but challenges remain the same

ChatGPT in medicine: STAT answers readers' burning questions

Statins may not be needed by millions of people, study suggests

Anesthesiologist group: stop taking Ozempic before surgery

Moderna says combo Covid

Wildfire smoke exposes gaps in outdoor worker protections

Eyeing GLP

Wikipedia

Eyeing GLP

Medical device trials still don't enroll enough women, study finds

Addressing health care workers' trauma can help fight burnout

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Questions and answers about ramping up H5N1 bird flu vaccine

entertainment

explore

knowledge

knowledge